Cargando…

Brain metastases admissions in Sweden between 1987 and 2006

BACKGROUND: Brain metastases (BM) constitute the most common intracranial tumours and are associated with considerable morbidity and mortality. Population-based studies of the epidemiology and time trends of BM are scarce. METHODS: A population-based cohort of patients admitted to hospital with BM i...

Descripción completa

Detalles Bibliográficos
Autores principales: Smedby, K E, Brandt, L, Bäcklund, M L, Blomqvist, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788258/
https://www.ncbi.nlm.nih.gov/pubmed/19826419
http://dx.doi.org/10.1038/sj.bjc.6605373
_version_ 1782174954752573440
author Smedby, K E
Brandt, L
Bäcklund, M L
Blomqvist, P
author_facet Smedby, K E
Brandt, L
Bäcklund, M L
Blomqvist, P
author_sort Smedby, K E
collection PubMed
description BACKGROUND: Brain metastases (BM) constitute the most common intracranial tumours and are associated with considerable morbidity and mortality. Population-based studies of the epidemiology and time trends of BM are scarce. METHODS: A population-based cohort of patients admitted to hospital with BM in Sweden between 1987 and 2006 (n=15 517) was identified and linked to nationwide registers of cancer incidence and death. Primary cancer types were assessed and time to hospitalisation and death was computed. RESULTS: The annual age-adjusted incidence rate of hospitalisation for BM doubled from 7 to 14 patients per 100 000 between 1987 and 2006. The most common primary tumours among women were lung (33%), breast (33%) and colorectal cancer (7%), and among men lung cancer (44%), malignant melanoma (12%) and colorectal cancer (9%). The increase was most evident for BM patients with lung cancer (both sexes) and breast cancer (women). Survival was short, with a median of 2.7 months. It varied little by cancer type and did not improve over calendar time. CONCLUSION: The number of patients admitted with BM has increased rapidly in Sweden. In spite of recent improvements in the prognosis of common primary cancer types, any parallel improvement among patients with advanced cancer and BM is not indicated.
format Text
id pubmed-2788258
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-27882582010-12-01 Brain metastases admissions in Sweden between 1987 and 2006 Smedby, K E Brandt, L Bäcklund, M L Blomqvist, P Br J Cancer Epidemiology BACKGROUND: Brain metastases (BM) constitute the most common intracranial tumours and are associated with considerable morbidity and mortality. Population-based studies of the epidemiology and time trends of BM are scarce. METHODS: A population-based cohort of patients admitted to hospital with BM in Sweden between 1987 and 2006 (n=15 517) was identified and linked to nationwide registers of cancer incidence and death. Primary cancer types were assessed and time to hospitalisation and death was computed. RESULTS: The annual age-adjusted incidence rate of hospitalisation for BM doubled from 7 to 14 patients per 100 000 between 1987 and 2006. The most common primary tumours among women were lung (33%), breast (33%) and colorectal cancer (7%), and among men lung cancer (44%), malignant melanoma (12%) and colorectal cancer (9%). The increase was most evident for BM patients with lung cancer (both sexes) and breast cancer (women). Survival was short, with a median of 2.7 months. It varied little by cancer type and did not improve over calendar time. CONCLUSION: The number of patients admitted with BM has increased rapidly in Sweden. In spite of recent improvements in the prognosis of common primary cancer types, any parallel improvement among patients with advanced cancer and BM is not indicated. Nature Publishing Group 2009-12-01 2009-10-13 /pmc/articles/PMC2788258/ /pubmed/19826419 http://dx.doi.org/10.1038/sj.bjc.6605373 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Smedby, K E
Brandt, L
Bäcklund, M L
Blomqvist, P
Brain metastases admissions in Sweden between 1987 and 2006
title Brain metastases admissions in Sweden between 1987 and 2006
title_full Brain metastases admissions in Sweden between 1987 and 2006
title_fullStr Brain metastases admissions in Sweden between 1987 and 2006
title_full_unstemmed Brain metastases admissions in Sweden between 1987 and 2006
title_short Brain metastases admissions in Sweden between 1987 and 2006
title_sort brain metastases admissions in sweden between 1987 and 2006
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788258/
https://www.ncbi.nlm.nih.gov/pubmed/19826419
http://dx.doi.org/10.1038/sj.bjc.6605373
work_keys_str_mv AT smedbyke brainmetastasesadmissionsinswedenbetween1987and2006
AT brandtl brainmetastasesadmissionsinswedenbetween1987and2006
AT backlundml brainmetastasesadmissionsinswedenbetween1987and2006
AT blomqvistp brainmetastasesadmissionsinswedenbetween1987and2006